M
0.752
0.03 (4.31%)
| Penutupan Terdahulu | 0.721 |
| Jumlah Dagangan | 201,652 |
| Harga / Jualan (P/S) | 36.76 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -0.770 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 416.80% |
| Nisbah Semasa (MRQ) | 4.66 |
| Aliran Tunai Operasi (OCF TTM) | -33.87 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -19.45 M |
| Pulangan Atas Aset (ROA TTM) | -41.29% |
| Pulangan Atas Ekuiti (ROE TTM) | -307.27% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Milestone Pharmaceuticals Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.8 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -2.0 |
| Penilaian Relatif | NA |
| Kesihatan Kewangan | -2.5 |
| Persekitaran Makro | -2.8 |
| AI Insight | NA |
| AI Technical | NA |
| Purata | -1.23 |
|
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR). |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 4.71% |
| % Dimiliki oleh Institusi | 22.25% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Pavaki Capital Management Llc | 30 Sep 2026 | 9,337,848 |
| Rvw Wealth, Llc | 30 Sep 2026 | 1,148,260 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |